Answer
It is unknown whether darolutamide or its metabolites pass into human breast milk; no animal studies have evaluated their excretion into milk, a risk to the breast-fed child cannot be excluded, and darolutamide must not be used during breast-feeding.
Sources for this answer
- NUBEQA 300 mg film coated tabletsBayer plc · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 11Document updated
Sources checked